Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listHydromorphone hydrochloride

Hydromorphone hydrochloride

Synonym(s):(5α)-4,5-Epoxy-3-hydroxy-17-methyl-morphinan-6-one hydrochloride;Hydromorphone HCl

  • CAS NO.:71-68-1
  • Empirical Formula: C17H20ClNO3
  • Molecular Weight: 321.8
  • MDL number: MFCD03427563
  • EINECS: 200-762-6
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-12-18 14:08:57
Hydromorphone hydrochloride Structural

What is Hydromorphone hydrochloride?

Description

Hydromorphone hydrochloride is a pure opioid agonist with the principal therapeutic activity of analgesia. It has an analgesic potency approximately two to eight times greater than that of morphine and has a rapid onset of action. A significant feature of the analgesia is that it can occur without loss of consciousness.

Chemical properties

White Solid

The Uses of Hydromorphone hydrochloride

Analgesic (narcotic). Preparation by electrolytic reduction of Morphine. Controlled substance (opiate).

Biochem/physiol Actions

Narcotic opiate analgesic; μ opioid receptor agonist.

Clinical Use

Hydromorphone is a potent μ agonist (eight times greater than morphine) that is used to treat severe pain. It is available in intramuscular, intravenous, subcutaneous, oral, and rectal dosage forms. Like all strong μ agonists, hydromorphone is addicting and is a Schedule II drug. Hydromorphone has an oral:parenteral potency ratio of 5:1. The plasma half-lives after parenteral and oral dosage are 2.5 and 4 hours, respectively.

Safety Profile

Poison by subcutaneous and intravenous routes. Experimental teratogenic effects. A powerful analgesic. When heated to decomposition it emits very toxic fumes of NOx and HCl. See also MORPHINE.

Drug interactions

Potentially hazardous interactions with other drugs
Alcohol: can cause dose dumping with sustained release preparations.
Analgesics: possible opioid withdrawal effects with buprenorphine and pentazocine.
Antidepressants: possible CNS excitation or depression with MAOIs - avoid concomitant use and for 2 weeks after stopping MAOI; possible CNS excitation or depression with moclobemide; increased sedative effects with tricyclics.
Antihistamines: increased sedative effects with sedating antihistamines.
Antipsychotics: enhanced hypotensive and sedative effects.
Dopaminergics: avoid with selegiline.
Nalmefene: avoid concomitant use.
Sodium oxybate: enhanced effect of sodium oxybate - avoid.

Metabolism

Hydromorphone undergoes extensive firstpass metabolism. It is extensively metabolised by glucuronidation in the liver and excreted in the urine mainly as conjugated hydromorphone, dihydroisomorphine, and dihydromorphine.

Properties of Hydromorphone hydrochloride

Melting point: >280°C (dec.)
alpha  D25 -133°
Density  1.1451 (rough estimate)
refractive index  1.6470 (estimate)
storage temp.  2-8°C
solubility  H2O: >10 mg/mL
form  A crystalline solid
EPA Substance Registry System Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, hydrochloride (1:1), (5.alpha.) (71-68-1)

Safety information for Hydromorphone hydrochloride

Signal word Warning
Pictogram(s)
ghs
Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H302:Acute toxicity,oral
H336:Specific target organ toxicity,single exposure; Narcotic effects

Computed Descriptors for Hydromorphone hydrochloride

Related products of tetrahydrofuran

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.